Debt to Equity Ratio Chart

View Debt to Equity Ratio for TECX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 0.0197
March 31, 2026 0.0201
December 31, 2025 0.0051
September 30, 2025 0.0046
June 30, 2025 0.0068
March 31, 2025 0.0087
December 31, 2024 0.0235
September 30, 2024 0.0198
June 30, 2024 0.0207
March 31, 2024 0.0025
December 31, 2023 -1.004
September 30, 2023 0.017
June 30, 2023 0.0195
March 31, 2023 0.346
December 31, 2022 0.2184
September 30, 2022 0.155
June 30, 2022 0.1276
March 31, 2022 0.1049
Date Value
December 31, 2021 0.0882
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.0565
Alnylam Pharmaceuticals, Inc. 2.206
Anika Therapeutics, Inc. 0.1839
Savara, Inc. 0.2117
Vericel Corp. 0.2556